Elsabah, H., Rola, G., Hamad, A., Benkhadra, M., Alasmar, A., Gulied, A., Mudawi, D., Shawaylia, H., Bakir, M., Cherif, H. (2025). Real-world assessment of early toxicities, treatment modifications, and outcomes with daratumumab, bortezomib, lenalidomide, and dexamethasone (D-VRd) in multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-7508